Monoclonal Antibodies for the Treatment of Multiple Myeloma: An Update

The past two decades have seen a revolution in multiple myeloma (MM) therapy with the introduction of several small molecules, mostly orally effective, whose mechanisms are based on proteasome inhibition, histone deacetylase (HDAC) blockade, and immunomodulation. Immunotherapeutic approaches to MM t...

Descripción completa

Detalles Bibliográficos
Autor principal: Abramson, Hanley N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321340/
https://www.ncbi.nlm.nih.gov/pubmed/30544512
http://dx.doi.org/10.3390/ijms19123924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321340/
https://www.ncbi.nlm.nih.gov/pubmed/30544512
http://dx.doi.org/10.3390/ijms19123924

Ejemplares similares